AlphaLife Sciences is an AI-first platform company transforming how novel therapies move from lab to market. Founded in 2020 and headquartered in New Jersey and Singapore, we combine deep regulatory expertise with AI innovation to eliminate critical bottlenecks in drug development. Our flagship platform, AuroraPrime, streamlines the entire submission lifecycle — covering nonclinical, clinical, CMC, safety, and labeling documentation — with built-in AI agents that automate data extraction, authoring, quality control, and cross-functional review. The result: compliant, submission-ready regulatory dossiers delivered with unprecedented speed across IND, NDA, BLA, and MAA filings.

Backed by a world-class team with over 80% of engineers from Google, Microsoft, and Medidata, and validated by strategic partners including Microsoft, NVIDIA, Veeva, and Johnson & Johnson, AlphaLife is setting the new standard in regulatory automation. Today, AuroraPrime is trusted by more than half of the top 20 global pharmaceutical companies to deliver enterprise-scale, regulatory-grade impact.